C61h88n18o16 - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

63775-95-1

环孢菌素B;
环[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰-3-羟基-N,4-二甲基-L-2

Cyclosporin B;
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alanyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]

Cyclosporin A,6-[(2S,3R,4R,6E)-3,8-dihydroxy-4-methyl-2-(methylamino)-6-octenoicacid]-9-L-leucine-;
CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoicacid]-9-L-leucine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
AM 14N;
Cyclosporin A metabolite 25;
M 25

Cyclosporin A,3-(4-hydroxy-L-leucine)- (9CI);
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.

Cyclosporin W (9CI);
CyclosporinA, 5-L-valine-7-L-threonine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-threonyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]

Cyclosporin A,3-(4-hydroxy-N-methyl-L-leucine)-9-L-leucine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
AM 4N9;
Cyclosporin A metabolite 13;
Cyclosporin Ametabolite 4N9

Cyclosporin A,9-L-leucine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
AM 4N;
Cyclosporin A metabolite 21;
Cyclosporin AM 4N;
M21;
OL 21;
[Leu4]cyclosporin

Cyclosporin B,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-alanine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.;
Cyclosporin B, dihydro-;
Dihydrocyclosporin B

Cyclosporin U (9CI);
CyclosporinA, 11-L-leucine-;
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.;
Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-L-leucyl]

L-Glutamic acid,N-(1-oxododecyl)-, bis[2-[(2-octyldodecyl)oxy]ethyl] ester (9CI);
bis[2-[(2-octyldodecyl)oxy]ethyl] N-(1-oxododecyl)-L-glutamate

Leucinostatin B (9CI);
LeucinostatinA, 9-[N-[1-methyl-2-(methylamino)ethyl]-b-alaninamide]-, [9(S)]-;
Antibiotic 1907-II;
b-Alaninamide, cis-4-methyl-1-(4-methyl-1-oxo-2-hexenyl)-L-prolyl-(4S,6S)-6-hydroxy-4-methyl-8-oxo-L-2-aminodecanoyl-threo-3-hydroxy-L-leucyl-2-methylalanyl-L-leucyl-L-leucyl-2-methylalanyl-2-methylalanyl-N-[1-methyl-2-(methylamino)ethyl]-,[1[S-(E)],9(S)]-

Mycoplanecin A (9CI);
1H,12H-Dipyrrolo[2,1-i:2',1'-r][1,4,7,10,13,16,19,22]oxaheptaazacyclopentacosine,cyclic peptide deriv.;
Stereoisomer of N-[N-[1-[N-[N-[1-[N-[N-[1-[N-(1,2-dioxobutyl)-N-methylvalyl]-4-ethylprolyl]-N-methylthreonyl]leucyl]-4-methylprolyl]-5-methylnorleucyl]-N-methylvalyl]prolyl]-N-methylleucyl]glyciney-lactone

Mycoplanecin A,1-[N-(2-hydroxy-1-oxobutyl)-N-methylvaline]- (9CI);
1H,12H-Dipyrrolo[2,1-i:2',1'-r][1,4,7,10,13,16,19,22]oxaheptaazacyclopentacosine,cyclic peptide deriv.

Trichopolyn V (9CI);
Alaninamide,1-(3-hydroxy-2-methyl-1-oxodecyl)-L-prolyl-6-hydroxy-4-methyl-8-oxo-L-2-aminodecanoyl-L-alanyl-2-methylalanyl-2-methylalanyl-L-isoleucyl-L-alanyl-2-methylalanyl-N-[2-[(2-hydroxyethyl)methylamino]-1-methylethyl]-2-methyl-

Uroguanylin (Didelphisvirginiana reduced) (9CI);
Guanylin(rat reduced), 1-L-glutamine-2-L-glutamic acid-3-L-asparticacid-6-L-leucine-8-L-isoleucine-9-L-asparagine-10-L-valine-;
106: PN:WO2005016244 PAGE: 26 unclaimed sequence;
247: PN: WO2008002971 PAGE: 4/5unclaimed sequence;
49: PN: US20060094658 SEQID: 49 claimed protein;
L-Cysteine, L-glutaminyl-L-a-glutamyl-L-a-aspartyl-L-cysteinyl-L-a-glutamyl-L-leucyl-L-cysteinyl-L-isoleucyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-

9,12-Octadecadienoicacid (9Z,12Z)-, 1,1',1''-[(methylstannylidyne)tris(thio-2,1-ethanediyl)] ester;
9,12-Octadecadienoicacid (9Z,12Z)-, (methylstannylidyne)tris(thio-2,1-ethanediyl) ester (9CI);
9,12-Octadecadienoic acid (Z,Z)-, (methylstannylidyne)tris(thio-2,1-ethanediyl)ester

9-Octadecenoic acid(9Z)-, 1,1',1''-[(methylstannylidyne)tris(thio-2,1-ethanediyl)] ester;
9-Octadecenoicacid (9Z)-, (methylstannylidyne)tris(thio-2,1-ethanediyl) ester (9CI);
9-Octadecenoic acid (Z)-, (methylstannylidyne)tris(thio-2,1-ethanediyl) ester;
Methyltin tris(2-mercaptoethyl oleate);
Monomethyltin tris(2-mercaptoethyloleate)

DYNAMIN INHIBITORY PEPTIDE, MYRISTOYLATED;
DYNAMIN INHIBITORY PEPTIDE, MYRISTOYLATED;
M.W. 1330.64 C61H107N19O14

ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2

H-ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2;
HK-1, MOUSE;
HK-1 (MOUSE, RAT);
H-ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2;
H2N-RSRTRQFYGLM-AMIDE;
HEMOKININ 1 (MOUSE);
HEMOKININ 1 (MOUSE, RAT);
HEK-1, MOUSE;
HEK-1 (MOUSE, RAT)

[NPHE1]NOCICEPTIN(1-13)NH2;
N-(BZL)GLY-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-NH2;
[NPHE1]NOCICEPTIN(1-13)NH2;
[N-PHE1]-NOCICEPTIN FRAGMENT 1-13 AMIDE

SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS;
SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS: SANSNPAMAPRERK

SOMATOSTATIN-28 (1-14);
H-SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS-OH;
SRIF 28 (1-14);
SOMATOSTATIN, HUMAN;
SOMATOSTATIN-28 (1-14);
SANSNPAMAPRERK;
SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS;
SOMATOSTATIN 28 FRAGMENT 1-14

C61H105N23O21S

详情

供应商

化工产品